Delivery Order 36F79720D0148-36C24526N0090
Award Date 10/7/25
Potential Completion Date 10/10/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the pharmaceutical product WAKIX 17.8 MG, awarded by the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a for-profit pharmaceutical company based in Plymouth Meeting, Pennsylvania. The contract has a ceiling value of $10,418.14 and is a firm fixed-price delivery order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract supports the supply of WAKIX to VA healthcare facilities nationwide for the treatment of...
- This federal contract award is for the delivery of WAKIX 17.8 MG tablets to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5. The $10,418.14 firm fixed price delivery order was awarded to Harmony Biosciences LLC, a for-profit pharmaceutical company that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The contract is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and supports...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a for-profit pharmaceutical company. The $10,418.14 contract is for the supply of WAKIX 17.8 mg, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract is issued under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of August 6, 2025. No set-aside...
- This is a federal contract award to Harmony Biosciences LLC, a pharmaceutical company based in Pennsylvania, for the procurement of WAKIX (pitolisant), a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract was awarded by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is a delivery order with a ceiling value of $39,243.48 and a period of performance ending on...
- This federal contract award is a delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications to treat rare neurological diseases and sleep disorders. The contract, valued at $5,209.07, is for the supply of WAKIX (pitolisant) 17.8 mg tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The...
- This federal contract award was made by the Veterans Health Administration, a component of the U.S. Department of Veterans Affairs, to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The contract is a delivery order with a firm fixed price of $10,418.14 and a completion date of August 22, 2025. It is part of a larger Blanket Purchase Agreement (BPA) valued at $25,000,000 and an Indefinite-Delivery Indefinite-Quantity (IDIQ)...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications to treat rare neurological diseases and sleep disorders. The contract is a delivery order against Harmony Biosciences' existing General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The award is for WAKIX...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC for the pharmaceutical product WAKIX 17.8 MG. The order, valued at $10,418.40, was placed against the VA's $5 million Blanket Purchase Agreement with Harmony Biosciences to supply WAKIX, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients, to VA healthcare facilities nationwide. Harmony...
- This federal contract award to Harmony Biosciences LLC, a pharmaceutical company, is a delivery order against the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Valued at $10,170.00, this firm-fixed-price order is for the medication WAKIX 17.8 MG, which is used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The order is placed by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to...
- This is a federal contract award to Harmony Biosciences LLC, a pharmaceutical company specializing in medications for rare neurological diseases and sleep disorders. The contract is a delivery order with a firm fixed price for the supply of WAKIX 17.8 mg tablets to the Department of Veterans Affairs (VA) through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has a ceiling value of $10,418.14 and a completion date of August 26, 2025. Harmony Biosciences LLC also...